(2-METHYL-PIPERIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 1g

2-(4-Ethoxy-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 500mg

7-Methoxy-N-(3-(trifluoromethyl)phenyl)quinoline-4-carboxamide, 95.0%, 250mg

2-(2-Fluoro-4-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

3-(2-Methoxy-ethoxy)propyne, 95%, 100mg

(4-Bromo-3-methylphenyl)acetic acid, 97.0%, 5g

1-(2-(Methylsulfonyl)ethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one, 95+%, 100mg

2-AMINO-BENZOTHIAZOLE-6-CARBALDEHYDE, 95.0%, 1g

3-Amino-5-bromo-2-methylbenzoic acid, 95+%, 5g

4-(4-Morpholinyl)benzoic Acid (contains 0.5% N,N-Dimethylformamide at maximum)>98.0%(GC)(T)5g

Toluiidrochinone, min 99%, per sintesi, 500 g, confezione plastica.

Protein L HRP Conjugate1vial

N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide, 95.0%, 100g